Publication:
Safety and effectiveness of a 2009 H1N1 vaccine in chronic kidney disease children

Simple item page
dc.contributor.buuauthorDönmez, Osman
dc.contributor.buuauthorAkacı, Okan
dc.contributor.buuauthorAlbayrak, Nurhan
dc.contributor.buuauthorAltaş, Ayşe Başak
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentRomatoloji Ana Bilim Dalı
dc.contributor.departmentÇocuk Nefrolojisi Ana Bilim Dalı
dc.contributor.orcid0000-0002-2148-1160
dc.contributor.researcheridAFO-2965-2022
dc.contributor.researcheridAAA-8778-2021
dc.contributor.scopusid19033971800
dc.contributor.scopusid36131105700
dc.date.accessioned2024-02-13T05:46:48Z
dc.date.available2024-02-13T05:46:48Z
dc.date.issued2014-08-04
dc.description.abstractBackground/Aims: Influenza vaccination is the most effective method for preventing influenza infection and its complications. The risk groups are children with chronic kidney diseases (CKDs) such as children on peritoneal dialysis (PD) and hemodialysis (HD), predialysis CKD (pCKD) and renal transplant (RTx) patients and immunosuppressed children. The aim of the present study was to assess the safety and immunogenicity of a single administration of a monovalent inactivated pandemic (H1N1) 2009 vaccine in children with CKD. Methods: Patients were given a single intramuscular injection of 0.5 ml of monovalent inactivated vaccine. Results: Totally, there were 25 pediatric patients with a diagnosis of CKD (16 PD, 2 HD, 3 pCKD and 4 RTx). Seroconversion was observed in 15 of the 16 patients with PD. Seroconversion occurred in all patients undergoing pCKD and HD. However, 3 of the RTx patients were seronegative. Conclusion: This study demonstrated a high level of immunogenicity and safety of an (H1N1) 2009 influenza vaccine in children with CKD. (C) 2014 S. Karger AG, Basel
dc.identifier.citationDönmez, D. vd. (2014). "Safety and effectiveness of a 2009 H1N1 vaccine in chronic kidney disease children". Nephron - Clinical Practice, 128(3-4), 341-344.
dc.identifier.endpage344
dc.identifier.issn1660-2110
dc.identifier.issue3-4
dc.identifier.pubmed25531752
dc.identifier.scopus2-s2.0-84922943511
dc.identifier.startpage341
dc.identifier.urihttps://doi.org/10.1159/000368410
dc.identifier.urihttps://karger.com/nec/article/128/3-4/341/831510/Safety-and-Effectiveness-of-a-2009-H1N1-Vaccine-in
dc.identifier.urihttps://hdl.handle.net/11452/39635
dc.identifier.volume128
dc.identifier.wos000349411500021
dc.indexed.wosSSCI
dc.language.isoen
dc.publisherKARGER
dc.relation.collaborationSanayi
dc.relation.journalNephron - Clinical Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectChild
dc.subjectRenal transplantation
dc.subjectChronic kidney diseases
dc.subjectInfluenza
dc.subjectDialysis
dc.subjectInfluenza-a h1n1
dc.subjectPandemic influenza
dc.subjectEfficacy
dc.subjectTransplant recipients
dc.subjectImmunization
dc.subjectHemodialysis-patients
dc.subjectUrology & nephrology
dc.subject.emtreeAdolescent
dc.subject.emtreeAntibody response
dc.subject.emtreeArticle
dc.subject.emtreeChild
dc.subject.emtreeChildhood disease
dc.subject.emtreeChronic kidney disease
dc.subject.emtreeClinical article
dc.subject.emtreeControlled study
dc.subject.emtreeDrug efficacy
dc.subject.emtreeDrug safety
dc.subject.emtreeFemale
dc.subject.emtreeHemagglutination inhibition
dc.subject.emtreeHemodialysis
dc.subject.emtreeHuman
dc.subject.emtreeImmunogenicity
dc.subject.emtreeInfluenza vaccination
dc.subject.emtreeMale
dc.subject.emtreePandemic
dc.subject.emtreePandemic influenza
dc.subject.emtreePeritoneal dialysis
dc.subject.emtreePredialysis chronic kidney disease
dc.subject.emtreePriority journal
dc.subject.emtreeRenal replacement therapy
dc.subject.emtreeSeroconversion
dc.subject.emtreeSingle drug dose
dc.subject.emtreeSyringe needle
dc.subject.emtreeComplication
dc.subject.emtreeHemodialysis
dc.subject.emtreeImmunocompromised patient
dc.subject.emtreeImmunology
dc.subject.emtreeInfluenza a virus (h1n1)
dc.subject.emtreeInfluenza, human
dc.subject.emtreeRenal insufficiency, chronic
dc.subject.emtreeTurkey
dc.subject.emtreeYoung adult
dc.subject.emtreeCalcineurin inhibitor
dc.subject.emtreeInactivated vaccine
dc.subject.emtreeInfluenza vaccine
dc.subject.emtreeMycophenolic acid
dc.subject.emtreePrednisolone
dc.subject.emtreeImmunosuppressive agent
dc.subject.emtreeInfluenza vaccine
dc.subject.meshAdolescent
dc.subject.meshChild
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunocompromised host
dc.subject.meshImmunosuppressive agents
dc.subject.meshInfluenza a virus, h1n1 subtype
dc.subject.meshInfluenza vaccines
dc.subject.meshInfluenza, human
dc.subject.meshMale
dc.subject.meshRenal dialysis
dc.subject.meshRenal insufficiency, chronic
dc.subject.meshTurkey
dc.subject.meshYoung adult
dc.subject.scopusHepatitis B Vaccine; Seroconversion; Vaccination
dc.subject.wosUrology & nephrology
dc.titleSafety and effectiveness of a 2009 H1N1 vaccine in chronic kidney disease children
dc.typeArticle
dc.wos.quartileQ3 (Urology & Nephrology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Nefrolojisi Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Romatoloji Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications